CAMERON ROBERT WOLFE

PERSONAL DETAILS:

Name: Cameron Robert Wolfe,

MBBS (Hons), MPH, CPDM, A.Mus.A

Office: (Ms Kelly Stanly) +1 919-668-0789

Facsimile: +1 919-684-8902

Email: cameron.wolfe@duke.edu

EDUCATION:

M.B.B.S. (Honours); University of Melbourne, 1995 – 2000

Master of Public Health (Health Policy & Management); 2013

UNC (Chapel Hill), North Carolina

Certificate in Community Preparedness & Disaster Management, CPDM,

UNC (Chapel Hill), North Carolina, 2010

Associate Diploma in Pianoforte: Performance; A.Mus.A, 1994, University of Sydney

Member of Infectious Diseases Society of America 2007 – present

Member of American Society of Transplantation 2012- present

Member of International Society for Heart and Lung Transplantation 2014 - presen

Member of American Society for Blood and Marrow Transplantation 2015 – present

CURRENT & PREVIOUS EMPLOYMENT:

Assistant Professor of Medicine: Division of Infectious Diseases & International Health

Bio-preparedness Director, Duke Preparedness and Response Center,

2009 – to current

Inpatient- Transplant ID Attending Physician: caring for solid organ

transplant recipients, recipients of cardiac support devices, patients with

malignant haematology related infections.

Outpatient- HIV and Transplant Infectious Diseases care;

Outreach HIV medicine - Southern Regional AHEC, Fayetteville, NC

Supervision of Fellows & Medicine residents in training programs;

Faculty, T32 Interdisciplinary Program in Transplant Infectious Disease

Faculty, T32 Interdisciplinary Research Training Program in AIDS;

Faculty, Duke Vaccine and Treatment Evaluation Unit

Medical Adjudication & Advisory panel, Duke BSL3 laboratory.

Infectious Disease liaison to University Student Health & Employee Health

Adjunct Lecturer: School of Public Health, University of North Carolina, Chapel Hill

2011 – to current

Lectures: Infectious Disease outbreaks; Bio-surveillance and bio-vigilance;

Globalisation and impacts on Infectious Disease

Infectious Diseases Fellowship, 2007-2008: Duke University Medical Center

Advanced Training Registrar, 2006-2007: Monash Medical Centre

Inc 6-months accredited microbiology laboratory rotations

Medical Residency, Advanced Registrar, 2001- 2005: St Vincent’s Hospital, Melbourne

CONSULTANT APPOINTMENTS:

Organ Procurement and Transplantation Network / United Network for Organ Sharing

(OPTN/UNOS) - Disease Transmission Advisory Committee; national organization to review

possible cases and consider issues and federal policy related to the transmission of disease and

malignancy through organ transplantation,

o appointed: 2012 – 2014;

o Vice Chair 2014-2016

o Chairman 2016-2019

Chair, OPTN/UNOS Failure Modes Effectiveness Analysis (FMEA) Taskforce– assessing

systems improvements in sharing new donor information with transplant recipient centers.

Infectious Disease Society of America, Influenza Guidelines national working group,

appointed 2013 - ongoing

Chairman, Independent Data Monitoring Committee (IDMC);

Consultant, External scientific and protocol development; GlaxoSmithKline – IV Zanamivir

for the treatment of hospitalized patients with influenza, 2010-present

Infectious Disease Society of America: Standards and Practice Guidelines Committee

member; appointed: 2012 – 2016. Liaison to Influenza and Lyme Disease Guidelines.

UNOS Committee member and NIH Review panel: HOPE Act Work Group 2014, to

implement guidelines regarding safe transplantation of HIV-infected organs in the United

States in accordance with Hope Act, Public Law 113-51, 113th U.S. Congress.

Committee Member, 2016 CDC Special Emphasis Panel: Emerging Infections Program,

CK17-1701

Lead Principal Investigator: Duke Clinical Research Institute – Gilead; GS-US-218-0108 &

218-1502 protocols for GS-5806 treatment of respiratory syncytial virus in hematopoietic

stem cell transplant recipients, awarded July 2014, terminated 2016

External Medical Consultant: GSK, Internal Safety Review Committee, Danirixin Outpatient

Influenza protocol, 2015-2016

Scientific Advisory Board: Invasive Aspergillosis and Rare Molds Virtual Advisory Network,

Astellas Pharma, US, Inc., 2015-2016

Medical Adjudication Panel: Cellerant – Phase II clinical trial investigating use of human

myeloid progenitor cells for prevention of infection during AML induction chemotherapy;

commencing 2014 - 2016.

Chairman, Independent Data Monitoring Committee (IDMC); Alios Biopharma, ALS-8176-

510 Phase 2/2b use of oral ALS-008176 for Respiratory Syncytial Virus infection, 2015-2016

Chairman, Independent Data Monitoring Committee (IDMC); JanssenBiotech,

VX787FLZ2001 and 636323872FLZ2002 Phase 2/3 protocols, treating patients with JNJ-

63623872 in combination with oseltamivir for active infection with influenza, 2015-2016

Independent Safety Monitor: Healthy Older Adult, Phase 2 MF59-Adjuvanted, Monovalent

Inactivated Influenza A/H7N9 Virus Vaccine Trial. Division of Microbiology and Infectious

Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID); Appointed

2014 - 2016

OPTN/UNOS Policy Oversight Committee: Appointed General member, 2014 – 2016

Independent Safety Monitor: Pharmacokinetics and Pharmacodynamics of Three Dosing

Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Subjects. Protocol: 15-0049

Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and

Infectious Diseases (NIAID); Appointed 2015-2016

ACADEMIC APPOINTMENTS and PARTICIPATION:

Current

Physician Lead, Duke University Health System: Ebola Response Taskforce, 2014 - 2015

Duke University Ebola Travel Exemption Oversight Committee

Co-Chair, Duke Influenza Vaccine Taskforce, 2010-present

Member of Hospital Infection Control Committee (HICC), 2010-present

Previous

Member of SERCEB (Southeast Regional Center for Excellence in Emerging Infections and

Biodefence) conference organizing committee, 2009-2014.

Co-Chair, North Carolina Hospital Influenza Taskforce, 2010-2012

Full board member of Duke Institutional Review Board, 2009-2013

Co-team leader for two Duke Hospital medical relief missions to Haiti, 2009

Duke University Course in Scientific Leadership and Management, 2010-11

AWARDS and SCHOLARSHIPS:

Duke University Hospital Strength, Hope and Caring Award, 2015 (Ebola management team)

North Carolina’s Best Doctors, Dec 2015

Duke University Blue Ribbon Teamwork award, 2014 (Influenza management team)

Duke University Hospital Strength, Hope and Caring Award, 2009 (individual patient care)

Duke University Hospital Fellow’s Teaching award, 2008

Australian Commonwealth John Flynn Scholarship, for work in an Aboriginal

community health network, 1997 – 2000

Rural Australia Medical Undergraduate Scholarship (RAMUS); awarded 2000

Chancellor’s Scholarship (Chemical Engineering); The University of Sydney, 1994

LECTURES & PRESENTATIONS:

International:

Wolfe CR: Lessons Learned from 2009 H1N1, Infectious Diseases Society of America 2010

Annual Meeting, Vancouver, Canada. Speaker, Session # 109, Sat 23rd October

Wolfe CR: Interactive Cases in Transplant, Interactive Panel; ID Week 2013, San Francisco,

Sat 5th, 2013

Wolfe CR, Schaenman, J: Top 10 papers in Transplant Infectious Disease, ID Week 2015,

San Diego, Thurs 8th, 2015

Wolfe CR: (on behalf of B.D.Alexander) Outbreak! Infection Clusters and the Transplant

Center, International Society for Heart and Lung Transplantation, 36th Annual Meeting and

Scientific Sessions; April 29, 2016

Wolfe CR: Donor-derived infections – Primer on Transplantation, ASM Microbe 2016,

Boston, Jun 17th, 2016

University:

Wolfe CR, Permar S, Moe J: Zika, an evolving challenge, Duke Innovation Challenge, Fuqua

School of Business, March 22, 2016

Wolfe CR, Woods C, Bali S, Merson, M: Domestic and International Lessions from Ebola,

Global Health Law and Policy Symposium, Duke University, Durham, NC, Nov 12, 2015

Wolfe CR: Infectious Diseases Complications for Transplant Recipients; Duke University 1st

Annual National Lung Transplant Symposium, August 2015

Wolfe CR: New Issues in Vaccinating Adults; Duke University Internal Medicine Feb, 2015

Wolfe CR: Vector borne illness in North Carolina, North Carolina State University, Student

Health, Dec 9, 2014

Wolfe CR: Hospital and Syndromic Surveillance Systems in Disaster Preparedness; Gillings

School of Public Health UNC-Chapel Hill, Community Preparedness & Disaster Management

Certificate lecture series, 2012-2014

Wolfe CR: Environmental and Public Health Surveillance after major disasters; Gillings

School of Public Health UNC-Chapel Hill, Community Preparedness & Disaster Management

Certificate lecture series, 2013-2014

Wolfe CR, Chen L: Ebola - an African Hot Zone; an American anxiety; Duke Pediatric Grand

Rounds, Oct 2014

Wolfe CR: The Globalization of Infectious Disease; Gillings School of Public Health UNC-

Chapel Hill, SPH-HPM-664, 2013

Wolfe CR: Appropriate use of antibiotics; North Carolina State University, Student Health,

Dec 10, 2013

Wolfe CR, Hollingsworth J, Cheifetz I: Pandemic Influenza: Challenges, Research & Clinical

Controversies; Duke University Grand Rounds, 2011

Wolfe CR: Urologic Care for the HIV patient; Duke University Urology Forum, Feb 2013

Wolfe CR: Challenging bioethics cases in the world of rationed healthcare; Duke University

Bioethics Conference, 2012, February

Wolfe CR, Greenwald IR, Woods C: Global Pandemics – Local Context; Duke University

Winter Forum, 2011, January 10th

Wolfe CR, et al: Cases in Medical Bioethics, Duke-UNC Bioethics Symposium, 2012

National:

Wolfe CR: National Reforms in Reporting of Transplant Donor-Derived Diseases;

Association of Organ Procurement Organizations Tri-Council Conference, Houston, Tx, Feb

3rd, 2016

Wolfe CR: Ebola Virus response –unique issues for an Academic Medical Center;

Association for Professionals in Infection Control, NC Chapter, Annual Conference, Raleigh,

Sept 2015

Wolfe CR: Hospital-based Response Opportunities to Ebola Virus in North Carolina; Ebola

Response: Globally to Locally, NC Communicable Diseases Conference, Raleigh, April, 2015

Wolfe CR: Emerging Infections in Transplantation; Association of Organ Procurement

Organizations Tri-Council Conference, Charleston, SC, Feb 11, 2015

Wolfe CR: Ebola – clinical and emergency preparedness updates , Halifax Regional

Hospital, South Boston, Virginia; Jan 26th, 2015

Wolfe CR: Infectious Disease Assessment in the Organ Donor, and Infectious Diseases in

Transplant; Invited Lectures, The NATCO (Organization for Transplant Professionals)

Annual Meeting, Tempe, AZ, June 2013.

Wolfe CR: Infectious Diseases in Transplantation and Infectious Disease Assessment in the

potential Organ Donor; Invited Lectures, The NATCO (Organization for Transplant

Professionals), Annual Meeting, Tempe, AZ, June 2014

Wolfe CR, Rupprecht C, Abrahamian F, Slate D: Rabies transmission and prevention,

SABoney & Associates, online webcast, June 2013

Wolfe CR: Updates in HIV care; Infectious Diseases Society of America, NC Chapter, 2012

Annual Meeting. Charlotte, Nov 17th, 2012.

Wolfe CR: Transgender health issues and Meds in HIV: New Developments; 30year later:

HIV conference 2012; Southern Regional AHEC, Fayetteville, NC, Nov 2012

Wolfe CR: Viral hepatitis – updates on Risks, Rates and Ravages; Infusion Nurses Society,

Annual Convention, 2011, Louisville, KN, May 23rd

Wolfe CR: HIV – toxicities, transmission and treatment; Infusion Nurses Society, Annual

Convention, Nashville, TN, 2009, May 5th

PUBLICATIONS: RF Chemaly, SL Aitken, CR Wolfe, R Jain, MJ Boeckh: Aerosolized Ribavirin: the most

expensive drug for pneumonia; Transplant Infectious Disease, 18 (3), 2016

Green, Michael; Covington, Shandie; Taranto, Sarah; Wolfe, Cameron; Bell, Walter; Biggins,

Scott W.; Conti, David; DeStefano, G. David; Dominguez, Edward; Ennis, Donna; Gross,

Thomas; Klassen-Fischer, Mary; Kotton, Camille; LaPointe-Rudow, Dianne; Law, Yuk;

Ludrosky, Kristen; Menegus, Marilyn; Morris, Michele I.; Nalesnik, Michael A.; Pavlakis,

Martha; Pruett, Timothy; Sifri, Costi; Kaul, Daniel; Donor-Derived Transmission Events in

2013: A Report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission

Advisory Committee, Transplantation, 2015 Feb;99(2):282-7

Argento C, Wolfe CR, Wahidi M, Shofer S, Mahmood K; Broncho-Mediastinal Fistula

Caused by Endobronchial Aspergilloma , Annals of the American Thoracic Society, 2015

Jan;12(1):91-5

Kaul D, Mehta A, Wolfe CR, Green M, Blumberg E; Ebola Virus Disease: Implications for

Solid Organ Transplantation; American Journal of Transplantation, Dec 15, 2014

Catania.J, Que.L, Govert.J, Hollingsworth.J, Wolfe.CR; High ICU admission rate for 2013-

2014 Influenza is associated with a low rate of vaccination; American Journal of Respiratory

and Critical Care Medicine, Vol. 189, No.4 (2014), pp. 485-487

Chen LF, Dailey NJ, Rao AK, Fleischauer AT, Greenwald I, Deyde VM, Moore ZS,

Anderson DJ, Duffy J, Gubareva LV, Sexton DJ, Fry AM, Srinivasan A, Wolfe CR., Cluster

of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infections on a Hospital

Ward among Immunocompromised Patients--North Carolina, 2009. Journal of Infectious

Diseases 2011 203: 838-846

Martin S, Hollingsworth C, Norfolk S, Wolfe, C and Hollingsworth J; Reversible cardiac

dysfunction associated with pandemic 2009 influenza A(H1N1) Chest. 2010

May;137(5):1195-7. Chest. 2010 May;137(5):1195-7

Brown-Elliott B, Iakhiaeva E, Griffith D, Woods G, Stout J, Wolfe CR, Turenne C and

Wallace R; In Vitro Activity of Amikacin Against Isolates of Mycobacterium avium complex

with Proposed MIC Breakpoints And Finding of a 16S rRNA Gene Mutation in Treated

Isolates, J Clin Microbiol. 2013 Oct;51(10):3389-94

Gargano L, Wolfe C, et al; Issues in the Development of a Research and Education

Framework for One Health Emerg Infect Dis 2013; Vol 19, Number 3

Biggs H, Chudgar S, Pfeiffer C, Rice K, Zaas A, Wolfe CR; Disseminated Mycobacterium

immunogenum infection presenting with septic shock and skin lesions in a renal transplant

recipient; Transplant Infectious Disease 2012

Martin, S, Hollingsworth C, Norfolk S, Wolfe C and Hollingsworth J; Response: Pandemic

H1N1 and cardiac dysfunction. Chest, 2011.

Lisa M. Gargano, Patrick F. Gallagher, Ashley S. Freeman, J. Glenn Morris, Susan

Temporado Cookson, Ian Greenwald, Paola Lichtenberger, Wilbur K. Milhous, Mildred

Williams-Johnson, Cameron Wolfe, Alexander Isakov, Christopher W. Woods, and James M.

Hughes; Academic Consortia: Untapped Resources for Preparedness, Response, and

Recovery—Examining the Cholera Outbreak in Haiti. Emerg Infect Dis 2011, 17(11) Epub

Oct 2011.

Wolfe CR. Case Report: Treatment of Chronic Osteomyelitis; Clin Infect Dis. 2011 Jun;52

Wolfe, CR and Hicks, C; Darunavir – A clinical review, HIV/AIDS – Research and Palliative

Care, 2009 (1):13-21, DOI 10.2147/HIV.S4842

Taylor SM, Wolfe CR, Dixon TC, Ruch DS, Cox GM; Wound botulism complicating the

internal fixation of a complex radial fracture, J Clin Microbiol. 2010 Feb;48(2):650-3. Epub

2009 Dec 9

Norfolk SG, Hollingsworth CL, Wolfe CR, Govert JA, Que LG, Cheifetz IM, Hollingsworth

JW.; Rescue therapy in adult and pediatric patients with pH1N1 influenza infection: a tertiary

center intensive care unit experience from April to October 2009; Crit Care Med. November

2010, 38(11), pp 2103-2107

Wolfe CR, Greenwald I, Chen L. Pandemic (H1N1) 20009 and oseltamivir resistance in

hematology/oncology patients. Emerg Infect Dis 2010, 16(11) p1808-1811

Wolfe CR; Staying Committed in Haiti; News & Observer; May 29, 2010

POSTER PRESENTATIONS and ABSTRACTS:

CR Wolfe, AR Wilk, CD Sifri, M Morris, A Mehta and D Kaul: Donor-derived

Toxoplasmosis in Solid Organ Transplant 2008-2015: Opportunities for improvement; 2016

American Transplant Congress, Boston, MA, June 12, 2016

AR Wilk, S Taranto, CR Wolfe, M. Nalesnik: Recipient Outcomes in U.S. Cases of Post-

Donation Living Donor Malignancy; 2016 American Transplant Congress, Boston, MA, June

13, 2016

ML Volk, AR Wilk, CR Wolfe, D Kaul: “PHS Increased Risk” label is associated with non-

utilizaqtion of hundreds of organs per year; 2016 American Transplant Congress, Boston,

MA, June 13, 2016

D Kaul, S Tlusty, A Wilk, and C Wolfe: A Decade of Donor-Derived Disease: A Report of

the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC); 2016 American

Transplant Congress, Boston MA, June 12, 2016

J. Schaenman, A Wilk, S Tlusty, M Michaels, CR Wolfe, D Kaul: Donor Derived Disease

Transmission Events in Thoracic Organ Transplantation: Data Reviewed by the OPTN Ad

Hoc Disease Transmission Advisory Committee; International Society for Heath and Lung

Transplantation Annual Meeting, Washington D.C., April, 2016. Abstract 2788

AW Baker, SS Lewis, BD Alexander, P Isaacs, LC Pickett, RJ Wallace Jr, BA Brown-Elliott,

N Strittholt, KC Hazen, CR Wolfe, EK Maziarz, JHoran, RD Davis, JM Reynolds, D

Anderson, DJ Sexton, LF Chen: A Cluster of Mycobacterium abscessus among Lung

Transplant Patients: Investigation and Mitigation; IDWeek, Oct 8, 2015, San Diego

R Bartz, J Hollingsworth, P Aguilar, K Klein, J Bohman, D Kor, H Babcock, D Schuller, B

Blough, A Swink, K Bartels, M Barron, A Babu, Lisa Boorman, M Cooter, M Daneshmand,

CR Wolfe, P Park: Outcomes of hospitalized influenza-positive patients at large

U.S.Extracorporaeal membrane oxygenation centers during 2013-2014 influenza season;

presented at American Thoracic Society 2015, Denver, May 2015

M Green, S Taranto, S Covington, M Michaels, C Wolfe, D Kaul; Pediatrics & Donor

Derived Disease Transmission: The US OPTN Experience; Oral Abstract, American

Transplant Congress; Philadelphia, May 6th, 2015

Epling C, Shulby G, Wolfe CR, Andolsek K; Transitioning Influenza Vaccination from a

Recommendation to a “Condition of Employmnt” for over 23,000 employees; presented at:

o NPSF Annual Patient Safety Congress, Austin, Tx, April 29, 2015

o International Forum on Quality and Safety in Health Care, April 24, 2015, London,

o DUHS Patient Safety Conference, Durham, March 2015

ME Clement, SG Norfolk, JM Reynolds, CR Wolfe, EKMaziarz: Prostate as Sanctuary Site:

Relapsed Blastomycosis in a Lung Transplant Recipient; International Society for Heart and

Lung Transplantation, Accepted for presentation - Nice, 2015. Abstract ID 2015-JF-2661-

ISHLT

Wolfe CR, Greenwald I, Thompson J; Telemedicine and its effects on disaster support team

member selection; International Conference on Emergency Medicine, June 2010, Abstract

ID : F-POS414/IT

Wolfe CR, Greenwald I, Thompson J; Academic medical centers and the creation of

international disaster support teams; International Conference on Emergency Medicine, June

2010, Abstract ID: T-POS191/DIS

Chen LF, Dailey NJ, Rao AK, Fleischauer AT, Greenwald I, Deyde VM, Moore ZS,

Anderson DJ, Duffy J, Gubareva LV, Sexton DJ, Fry AM, Srinivasan A, Wolfe CR; Cluster

of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Among

Immunocompromised Patients on a Hospital Ward — North Carolina; SHEA Decennial

International Conference on Healthcare-Associated Infections; March 2010, Abstract ID:

3013

C. Wolfe, D. Turner, C. Rudd, J. Pham, I. Cheifetz; Intravenous Zanamivir for Critical Illness

due to Pandemic H1N1 Influenza, SCCM, 40TH Critical Care Conference; Jan, 2011,

Abstract ID: 777

D.Kaul, C.Wolfe, et al; Time to Presentation of Donor Derived Infection; 2013 American

Transplant Congress, May 18, 2013; Abstract ID: B1038

CR Wolfe, C.Kotton, D.Kaul, M.Green, S.Taranto, M.Morris; Geographic variation in donor-

derived transplant infections; 2014 World Transplant Congress, Seattle, July, 2014

L.Porras, B.Boggess, CR Wolfe; Scarier than Acne: Chronic Shoulder Pain Caused By P.

Acnes Septic Arthritis; American Medical Society for Sports Medicine, 2014

M Green, S Covington, S Taranto, W Bell, SW Biggins, E Blumberg, G DeStafano, E

Dominguez, D Ennis, T Gross, M Klassen-Fischer, C Kotton, S Kusne, Y Law, M Menegus,

R Miller, M Pavlakas, T L Pruett, D LaPointe-Rudow, P Ruiz, N Siparsky, M Souter, L

Weiss, C Wolfe and D Kaul: Donor Derived Transmission Events in 2012: A Report of the

OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC); 2013 American

Transplant Congress, May 2013

S Kusne, S Taranto, S Convington, D Kaul … C Wolfe and M Green: Transmission of

Coccidioidomycosis through Organ Transplantation; oral abstract, 2013 American Transplant

Congress, May, 18, 2013

M Green, S Covington, S Taranto, …, C Wolfe and D Kaul: A report of the OPTN Ad Hoc

Disease Transmission Advisory Committee (DTAC); oral abstract, 2014 World Transplant

Congress, Seattle, July 2014,

BOOK CHAPTERS:

Wolfe CR and Visvanathan, K; Chapter - Rheumatic Fever , Infectious Diseases, Cohen,

Powderly, Opal et al, 3rd Edition, 2009 Elsevier

Wolfe CR; Identifying & managing casualties of biological terrorism; UpToDate, Edition

18.4, 2012.

NOTABLE ACHIEVEMENTS:

The London International Youth Science Forum, 1993; Australian Representative; including:

o Queen’s Trust Scholarship, 1993

Australia Day Young Citizen nominee; 1994

Team Leader; International Physics Olympiad, Canberra 1995; Canada 1997

Student representative and staff member, CRA National Youth Science Forum; 1993 -1995

EXTRA MEDICAL ACTIVITIES:

Conference Organizing Committee:

2010 SERCEB conference: Engaging Public Health, Academia and

Research in Pandemic Preparedness,

2010 SERCEB conference: Role of Academic Medical Centers in

international and local disaster relief,

2011 SERCEB conference: Examining the Role of Academic Consortia in

Epidemic Preparedness, Response, and Recovery – Cholera in Haiti

2012 SERCEB/SECEPT conference: Developing a Research and Education

Agenda for One Health,

Ad hoc Manuscript Reviewer:

o Blood, 2015- 2016

o Clinical Infectious Diseases, 2014-2016

o American Journal of Transplantation, 2012 – 2016

o Journal of Heart and Lung Transplantation, 2012 – 2016

o Transplant Infectious Diseases, 2014 - 2016

o BMC Infectious Diseases 2014 - 2015

o North Carolina Medical Journal 2014

o Oxford University Press – HIV publications, 2012 - 2013

o DovePress: HIV/AIDS - Research and Palliative Care, Neurobehavioral HIV

Medicine, 2010

Volunteer Physician, 2002:

East Timor: 13 weeks associated with Jesuit Refugee Service: Maliana

District Hospital, East Timor

Ethiopia: 8 weeks associated with Missionaries of Charity, Mother Theresa

Sisters: Hiv/A.I.D.S. Hospice, Addis Ababa; again, Oct 2012.

Rwanda: 8 weeks associated with World Vision, East Africa, Gahini

District Hospital

Kenya: 4 weeks associated with World Vision, East Africa, working in

Kibera, Nairobi.

Medical Electives,2000 – 3 months spent in:

Malawi: St John’s Hospital, Mzuzu– Medicine

Kenya: Kikuyu Hospital, Kikuyu– Orthopaedics, Trauma

Uganda: Kisiizi Hospital, Uganda– Medicine

Tutor: Pathology, Histology, Histopathology, Embryology, Queen’s College,

1999-2001, 2003

Melbourne University Rural and Remote Medicine Club (“Outlook”)

Vice-President, Secretary and Chairman; Queen’s College Sports & Social Club;

1996-1998 respectively

Queen’s College Council, Melbourne University, 1997

CURRENT & PREVIOUS FUNDING:

NIEHS, Grant Number: 1UH4ES027072-01

Ebola Biosafety and Infectious Disease Response Training

June 2016 – May 2019

Project Title: Duke Infectious Disease Response Training Consortium (DIDRT) Dr Wolfe is a co-Principal Investigator at the lead site, Duke University, working together

with faculty from the Duke Human Vaccine Institute and the Regional Biocontainment

Laboratory to create teaching and training modules for biosafety training specific to Ebola

virus and other novel emerging pathogens

NIAID, SSS CRB-DCR01-5-09-00318*

12/01/09 - 2013

Active

Influenza Research Collaborative Sites Combination Therapy Working Group Dr Wolfe is a representative of Duke University Health System providing leadership

regarding combination chemotherapeutic development for influenza.

Merck – MISP

02/01/12 – current

Active

Raltegravir Use in HIV patients receiving Solid Organ Transplantation

Dr Wolfe is the PI of a Duke University investigator-initiated, industry-funded study of

Raltegravir as an antiretroviral drug of choice for HIV patients with organ transplantation.

UNC – SERCEB, W00445725-30733

03/1/11 – 2014

Active

Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Dr Wolfe is an investigator on a regional biodefense and emerging infection grant centered at

University of North Carolina at Chapel Hill.

ACTG Adult AIDS Clinical Trials Unit (Thielman), NIH 5U01AI069484-04

12/06 - 2015

Active

To develop and implement hypothesis-driven, pathogenesis-based innovative clinical

trials for persons with HIV infection. Dr Wolfe is a co-investigator.

Glaxo Smith Kline – NAI 114373

10/18/10 – current

Active

Zanamivir for the treatment of severe influenza Dr Wolfe assists with statistics, safety and development of protocols for analysis of influenza

treatment options.

Research Grant – Roche

2011-2014

Active

Oseltamivir dosing for influenza in immunocompromised patients Dr Wolfe is a local PI at the Duke University site.

Research Grants – NIAID/Insight: FLU002, FLU003, FLU004, IRC003, FLU006-IVIG

2011- current

Active

Dosing and observational studies for influenza Dr Wolfe is a local PI at the Duke University site for five independently run NIH-funded

influenza studies observing treatment outcomes for high-risk outpatients and inpatients.

Research Grant – Ansun Biopharma

2013- current

Active

Use of DAS-181 for treat of Parainfluenza infection in immunocompromised patients

Dr Wolfe is a local PI at the Duke University site

SAMPLE MEDIA PRESENTATIONS:

Mary Brophy Marcus: Vaccine arrives as flu spreads; USA Today, Oct 6, 2010

o http://www.usatoday.com/news/health/2009-10-06-swine-flu-vaccine_N.htm

WRAL news, Oct 12, 2009 http://www.wral.com/news/local/video/6198033/

Sarah Avery: Duke concerned about drug resistant swine flu; The Charlotte Observer, Nov

21, 2009

o http://www.charlotteobserver.com/2009/11/21/1068072/duke-concerned-about-drug-

resistant.html

Radio: Here’s to your health: H1N1 influenza vaccination; 1360 WCHL, Feb 10, 2010;

The Herald Sun: Matthew Milliken: Duke medical team heading to Haiti; Feb 4, 2010

o http://www.heraldsun.com/view/full_story/5767274/article-Duke-medical-team-

heading-to-Haiti?instance=most_recommended

ABC 11 news: Duke doctors head to Haiti; Feb 4, 2010-08-1

o http://abclocal.go.com/wtvd/story?section=news/local&id=7257000

MedPage Today, Infectious Disease, West Nile Cost: $778 Million; Feb 10, 2014

o http://www.medpagetoday.com/InfectiousDisease/GeneralInfectiousDisease/44232

Radio WPTF-Talk Radio 850AM: http://www.wptf.com/ mp3 available upon request.

o Jan 6, 2014 Compare: Josh Zach, Topic: Infectious Disease Preparedness

o Jan 6, 2014 Compare: Josh Zach, Topic: Cold Temperatures and Flu Season

o Jan 7, 2014 Compare: Josh Zach, Topic: Duke Medicine restricts hospital visitation

o Feb 28, 2014 Compare: Brandon Dickson, Topic: Influenza mortality and spread

o Jan 29, 2016 Compare: Josh Zach, Topic: Zika virus infections and pregnancy

Forbes.com: David Knoll: More proof the flu vaccine works; Feb 16, 2014

o http://www.forbes.com/sites/davidkroll/2014/02/16/more-proof-the-flu-vaccine-

works/

US News & World Report: Flu hits unvaccinated hardest study finds; Feb 14, 2014

o http://health.usnews.com/health-news/articles/2014/02/14/flu-hits-unvaccinated-

hardest-study-finds

National Public Radio (NPR), Maanvi Singh: With this year’s flu young adults are not so

invincible; Feb 13, 2014

o http://www.npr.org/blogs/health/2014/02/12/276025918/with-this-years-flu-young-

adults-are-not-so-invincible

New York Times, Nicholas Bakalar: Young adults need flu shots too; Feb 12, 2014

o http://well.blogs.nytimes.com/2014/02/12/young-adults-need-flu-shots-

too/?_php=true&_type=blogs&_php=true&_type=blogs&_php=true&_type=blogs&

_php=true&_type=blogs&_php=true&_type=blogs&_php=true&_type=blogs&_r=5

Futurity, Monique Patenaude: Young adults who skip flu shot show most severe symptoms;

Feb 11, 2014

o http://www.futurity.org/young-unvaccinated-adults-account-severest-flu-cases/

The Herald-Sun, Keith Upchurch; Duke would be ready for Ebola case; Aug 14, 2014

o http://www.heraldsun.com/news/showcase/x571857220/Duke-would-be-ready-for-

Ebola-case

CBS News, ABC News, Marilynn Marchione; Zmapp cures monkeys of Ebola virus; Aug 29,

2014, Associated Press

o http://www.cbsnews.com/news/zmapp-cures-monkeys-of-ebola-virus/

o http://abcnews.go.com/Health/wireStory/experimental-ebola-drug-heals-monkeys-

study-25179843?singlePage=true

National Public Radio, Leoneda Inge, Is North Carolina Prepared for Ebola?; October 9,

2014, WUNC 91.5;

o http://wunc.org/post/north-carolina-prepared-ebola

The Conversation, Even with mismatches flu shots can keep you from getting sick. December

9, 2014

o https://theconversation.com/even-with-mismatches-flu-shots-can-still-keep-you-

from-getting-sick-35151

EverydayHealth.com, Jennifer Brown: 10 Essential Facts about Whooping Cough; published

2015-02-20

o http://www.everydayhealth.com/news/10-essential-facts-about-whooping-cough/

CBSNews.com, Ashley Welsh: Many Americans with HIV don't know they're infected; June

26, 2015

o http://www.cbsnews.com/news/many-americans-with-hiv-dont-know-theyre-

infected/

WNCN, Emma Wright; Duke specialist says Zika virus currently not a threat in the US, Jan

29th, 2016

o http://wncn.com/2016/01/29/duke-specialist-says-zika-virus-not-currently-a-threat-

in-us/

TimeWarnerCable News 14, Chris Williams; Duke Doctor: Zika vaccine is years away; Jan

29th, 2016

o http://www.twcnews.com/nc/triangle-sandhills/news/2016/01/29/duke-doctor--zika-

vaccine-is-years-away.html